{"entity":{"id":"3552c0b8-712d-5b45-aeea-de313c2fcf8e","name":"SPIEGELMAN DANIEL K","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001238403","risk":"LOW","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"asset":{"id":"dd91eb35-a8ad-5def-97d9-315d460750d5","name":"Maze Therapeutics, Inc.","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"sec_edgar","source_url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001238403"}],"source":"corpus"}